Mechanism of synergistic induction of DNA synthesis by epidermal growth factor and tumor promoters

L. M. Matrisian, G. T. Bowden, B. E. Magun

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Evidence is presented to support our previously proposed hypothesis that the hyperplastic effect of tumor promoters is related to their ability to alter existing physiological levels of growth factors in target tissues. Epidermal growth factor and phorbol ester tumor promoters acted synergistically at low (0.001-0.05 ng/ml) but not high (>0.1 ng/ml) EGF concentrations to induce DNA synthesis in cultured Rat-1 fibroblast cells. The degree of synergism correlated with the tumor-promoting ability of the compound. The tumor promoters decreased 125I-EGF binding to cellular receptors in a dose-dependent manner that also correlated with the tumor-promoting ability of the compound. The inhibition of EGF binding by phorbol ester compounds resulted in a decrease in the amount of EGF degraded as compared to control cultures. At limiting EGF concentrations, the sparing of EGF degradation resulted in an increase in the amount of EGF remaining in the culture medium after 12 h of incubation and a concomitant increase in the amount of EGF bound to phorbol ester-treated cells at this time as compared to control cultures. The ability of a phorbol ester compound to alter EGF degradation and to stimulate DNA synthesis synergistically with EGF correlated with the tumor-promoting ability of the compound and occurred only at low EGF concentrations.

Original languageEnglish (US)
Pages (from-to)417-425
Number of pages9
JournalJournal of Cellular Physiology
Volume108
Issue number3
StatePublished - 1981
Externally publishedYes

Fingerprint

Epidermal Growth Factor
Carcinogens
DNA
Phorbol Esters
Tumors
Cells
Degradation
Neoplasms
Fibroblasts
Cell culture
Culture Media
Rats
Intercellular Signaling Peptides and Proteins
Tissue

ASJC Scopus subject areas

  • Cell Biology
  • Clinical Biochemistry
  • Physiology

Cite this

Mechanism of synergistic induction of DNA synthesis by epidermal growth factor and tumor promoters. / Matrisian, L. M.; Bowden, G. T.; Magun, B. E.

In: Journal of Cellular Physiology, Vol. 108, No. 3, 1981, p. 417-425.

Research output: Contribution to journalArticle

Matrisian, L. M. ; Bowden, G. T. ; Magun, B. E. / Mechanism of synergistic induction of DNA synthesis by epidermal growth factor and tumor promoters. In: Journal of Cellular Physiology. 1981 ; Vol. 108, No. 3. pp. 417-425.
@article{a2f6f66a47a74d3b9a585c7df937e32f,
title = "Mechanism of synergistic induction of DNA synthesis by epidermal growth factor and tumor promoters",
abstract = "Evidence is presented to support our previously proposed hypothesis that the hyperplastic effect of tumor promoters is related to their ability to alter existing physiological levels of growth factors in target tissues. Epidermal growth factor and phorbol ester tumor promoters acted synergistically at low (0.001-0.05 ng/ml) but not high (>0.1 ng/ml) EGF concentrations to induce DNA synthesis in cultured Rat-1 fibroblast cells. The degree of synergism correlated with the tumor-promoting ability of the compound. The tumor promoters decreased 125I-EGF binding to cellular receptors in a dose-dependent manner that also correlated with the tumor-promoting ability of the compound. The inhibition of EGF binding by phorbol ester compounds resulted in a decrease in the amount of EGF degraded as compared to control cultures. At limiting EGF concentrations, the sparing of EGF degradation resulted in an increase in the amount of EGF remaining in the culture medium after 12 h of incubation and a concomitant increase in the amount of EGF bound to phorbol ester-treated cells at this time as compared to control cultures. The ability of a phorbol ester compound to alter EGF degradation and to stimulate DNA synthesis synergistically with EGF correlated with the tumor-promoting ability of the compound and occurred only at low EGF concentrations.",
author = "Matrisian, {L. M.} and Bowden, {G. T.} and Magun, {B. E.}",
year = "1981",
language = "English (US)",
volume = "108",
pages = "417--425",
journal = "Journal of Cellular Physiology",
issn = "0021-9541",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - Mechanism of synergistic induction of DNA synthesis by epidermal growth factor and tumor promoters

AU - Matrisian, L. M.

AU - Bowden, G. T.

AU - Magun, B. E.

PY - 1981

Y1 - 1981

N2 - Evidence is presented to support our previously proposed hypothesis that the hyperplastic effect of tumor promoters is related to their ability to alter existing physiological levels of growth factors in target tissues. Epidermal growth factor and phorbol ester tumor promoters acted synergistically at low (0.001-0.05 ng/ml) but not high (>0.1 ng/ml) EGF concentrations to induce DNA synthesis in cultured Rat-1 fibroblast cells. The degree of synergism correlated with the tumor-promoting ability of the compound. The tumor promoters decreased 125I-EGF binding to cellular receptors in a dose-dependent manner that also correlated with the tumor-promoting ability of the compound. The inhibition of EGF binding by phorbol ester compounds resulted in a decrease in the amount of EGF degraded as compared to control cultures. At limiting EGF concentrations, the sparing of EGF degradation resulted in an increase in the amount of EGF remaining in the culture medium after 12 h of incubation and a concomitant increase in the amount of EGF bound to phorbol ester-treated cells at this time as compared to control cultures. The ability of a phorbol ester compound to alter EGF degradation and to stimulate DNA synthesis synergistically with EGF correlated with the tumor-promoting ability of the compound and occurred only at low EGF concentrations.

AB - Evidence is presented to support our previously proposed hypothesis that the hyperplastic effect of tumor promoters is related to their ability to alter existing physiological levels of growth factors in target tissues. Epidermal growth factor and phorbol ester tumor promoters acted synergistically at low (0.001-0.05 ng/ml) but not high (>0.1 ng/ml) EGF concentrations to induce DNA synthesis in cultured Rat-1 fibroblast cells. The degree of synergism correlated with the tumor-promoting ability of the compound. The tumor promoters decreased 125I-EGF binding to cellular receptors in a dose-dependent manner that also correlated with the tumor-promoting ability of the compound. The inhibition of EGF binding by phorbol ester compounds resulted in a decrease in the amount of EGF degraded as compared to control cultures. At limiting EGF concentrations, the sparing of EGF degradation resulted in an increase in the amount of EGF remaining in the culture medium after 12 h of incubation and a concomitant increase in the amount of EGF bound to phorbol ester-treated cells at this time as compared to control cultures. The ability of a phorbol ester compound to alter EGF degradation and to stimulate DNA synthesis synergistically with EGF correlated with the tumor-promoting ability of the compound and occurred only at low EGF concentrations.

UR - http://www.scopus.com/inward/record.url?scp=0019458618&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019458618&partnerID=8YFLogxK

M3 - Article

C2 - 6270169

AN - SCOPUS:0019458618

VL - 108

SP - 417

EP - 425

JO - Journal of Cellular Physiology

JF - Journal of Cellular Physiology

SN - 0021-9541

IS - 3

ER -